Diabetes mellitus represents one of the foremost global health challenges, underpinned by a complex interplay of genetic predisposition, environmental influence and metabolic dysfunction. Contemporary ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

Natco Pharma has launched a new generic semaglutide injection in India. This marks a significant step in making advanced ...

Immunotherapy. 2011;3(11):1303-1306. As discussed above, the proof-of-principle studies using both anti-CD3 antibodies (teplizumab and otelixizumab) showed effects on surrogate markers (C-peptide ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme.

Diabetes insipidus is a condition that causes excess urine production and persistent thirst. Syndrome of inappropriate antidiuretic hormone (SIADH) causes your body to retain too much water. Diabetes ...

This guide explains diabetes insipidus, including common symptoms, hormone causes, diagnosis tests, and medical treatment options for long-term management.

Neonatal diabetes is an uncommon disease that affects infants within the first 6 months of life where the baby is unable to ...